AMTX - Company ID 0000738214
AEMETIS, INC trades as AMTX. In its fiscal 2025 annual report the company posted revenue of $197.63M, down 26.2% from the prior year and net income of -$77.00M. This page tracks AEMETIS, INC through 851 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years AEMETIS, INC's revenue grew from $143.16M to $197.63M, a compound annual growth rate of 3.6%. Net profit margin compressed from -10.9% to -39.0% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-26 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
| Proxy statement | DEF 14A | 2026-04-07 |
| Insider trade | 4 | 2026-03-23 |
| Insider trade | 4 | 2026-03-23 |
| Insider trade | 4 | 2026-03-23 |
| Insider trade | 4 | 2026-03-23 |
The largest companies sharing AEMETIS, INC's SEC industry classification (industrial organic chemicals).
AEMETIS, INC reported revenue of $197.63M for fiscal year 2025, a decrease of 26.2% year over year.
In its latest fiscal year AEMETIS, INC reported a net loss of $77.00M.